« Previous
Next »
Fertility and Sterility
Volume 82, Issue 4
, Pages 841-846
, October 2004
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization
References
- . Diagnosis, prevention and management of ovarian hyperstimulation syndrome . Br J Obstet Gynaecol . 1995;102:767–772
- . Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention . Fertil Steril . 1990;53:502–509
-
.
Ovarian hyperstimulation syndrome
.
In:
Adashi E
, Rock J
, Rosenwaks Z
editor. Reproductive endocrinology, surgery and technology
. New York: Raven Press; 1995;p. 649–679
- . Risk factors and prognostic variables in ovarian hyperstimulation syndrome . Am J Obstet Gynecol . 1988;159:210–215
- Severe ovarian hyperstimulation syndrome: role of peripheral vasodilatation . Fertil Steril . 1991;56:1077–1083
- Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome . J Clin Endocrinol Metab . 1995;80:1967–1971
- . Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report . Fertil Steril . 1996;65:552–555
- . Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization . Fertil Steril . 1997;68:305–311
- . Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome . Hum Reprod . 2000;15:1037–1042
- . Plasma levels of free vascular endothelial growth factor 165 (VEGF 165) are not elevated during gonadotrophin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls . Eur J Obstet Gynecol Reprod Biol . 2001;96:196–201
- . “Prolonged coasting”: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization . Hum Reprod . 1995;10:3107–3109
- . Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome . Fertil Steril . 1997;67:724–727
- . Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety . Hum Reprod . 1999;14:1457–1460
- . The luteinizing hormone surge—the final stage in ovulation induction: modern aspects of ovulation triggering . Fertil Steril . 1995;64:237–251
- . Severe OHSS: how many cases are preventable? . Hum Reprod . 2000;15:8–10
-
.
Human in vitro fertilization and embryo transfer
.
New York: Plenum Press; 1984;
- . Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome . Eur J Obstet Gynecol Reprod Biol . 2001;97:208–212
- . Albumin in the prevention of severe OHSS . Hum Reprod . 1999;14:1664
- . Human chorionic gonadotropin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme . Hum Reprod . 1995;10:1667–1670
- . The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program . Fertil Steril . 1987;48:958–963
- . Effects of varying doses of hCG on the evolution of preovulatory rabbit follicles and oocytes . Hum Reprod . 1989;4:636–642
- . Role of the amplitude of the gonadotropin surge in the rat . Fertil Steril . 1990;53:150–154
- . Luteinizing hormone requirements for ovulation in the rat . Biol Reprod . 1992;46:1144–1150
- . Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin . Hum Reprod . 1997;12:1877–1885
- . Low plasma levels of hCG after 10,000-IU hCG injection do not reduce the number or maturation of oocytes recovered in patients undergoing assisted reproduction . J Assist Reprod Genet . 1998;15:583–586
- Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization . J Clin Endocrinol Metab . 2002;87:709–715
PII: S0015-0282(04)02223-X
doi: 10.1016/j.fertnstert.2004.03.055
© 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 82, Issue 4
, Pages 841-846
, October 2004

